Hosted on MSN
The impact of bio-convergence in healthcare
In 2024, the Israel Innovation Authority (IIA) unveiled plans to invest $35m into its first laboratory focused on advancing the field of bio-convergence. The initiative underscores the country's ...
BOSTON and SEOUL, South Korea, Jan. 5, 2026 /PRNewswire/ -- Xellar Biosystems ("Xellar"), a globally leading innovator in next-generation artificial intelligence- and computer vision–assisted, ...
Innovative bio-convergence lab to propel Israel as a global leader in smart medical diagnostics, environmental restoration, and sustainable energy generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results